Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
Meta Roestenberg(Radboud University Medical Center), Robert W. Sauerwein(Radboud University Nijmegen)
Cited by 90
Related Papers
Outcomes of controlled human malaria infection after BCG vaccination
|Nature Communications|2019|223